Nathaniel Calloway - Apr 4, 2025 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Director
Signature
/s/ Daniel George, as attorney-in-fact
Stock symbol
ANEB
Transactions as of
Apr 4, 2025
Transactions value $
$0
Form type
4
Date filed
4/7/2025, 09:41 PM
Previous filing
Jul 10, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANEB Stock Option (right to buy) Award $0 +25K $0.00 25K Apr 4, 2025 Common Stock 25K $1.02 Direct F1
transaction ANEB Stock Option (right to buy) Award $0 +3.31K $0.00 3.31K Apr 4, 2025 Common Stock 3.31K $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.